Attune Pharmaceuticals, Inc. — Form D
Attune Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-29. The offering totals $23.6M, of which $23.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-06-29
- Form: D
- Accession: 0001744769-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $23.6M
- Amount sold: $23.3M
- Remaining: $265K
- Investors: 11
- Date of first sale: 2018-06-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-315744
Issuer
- Name: Attune Pharmaceuticals, Inc.
- CIK: 0001744769
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 250 WEST 55TH STREET, 34TH FLOOR, NEW YORK, NY, 10019
- Phone: 1-646-597-6987
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Andrew McDonald | Director | NEW YORK, NY |
| Adam Tomasi | Director | NEW YORK, NY |
| Roderick Wong | Director | New York, NY |
| Jason Bablak | Executive Officer | Pittsburgh, PA |
| Andrew McDonald | Executive Officer | NEW YORK, NY |
More